Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B

Area of Science:

• Immunology
• Hepatology
• Oncology

Background:

• Chronic Hepatitis B Virus (HBV) infection is a major cause of liver diseases, including cirrhosis and hepatocellular carcinoma (HCC).
• Host immune responses and chronic inflammation are key drivers in the progression of HBV-related liver disease.
• Identifying predictive markers for liver disease progression is crucial for early intervention.

Purpose of the Study:

• To investigate the association between plasma immune markers and the development of cirrhosis and HCC in chronically HBV-infected individuals.
• To assess the predictive capability of these markers for liver disease progression.

Main Methods:

• Prospective cohort study involving 175 HCC, 117 cirrhotic, and 165 non-cirrhotic control participants.
• Analysis of 102 plasma markers using multivariable polytomous logistic regression and canonical discriminant analysis (CDA).
• Receiver operating characteristic (ROC) curves and leave-one-out cross-validation were used to evaluate predictive accuracy.

Main Results:

• Six markers (HGF, SLAMF1, CSF1, uPA, IL-8, OPG) were significantly associated with cirrhosis development compared to controls, with a combined prediction accuracy of 69%.
• A nine-marker model identified through CDA demonstrated a higher accuracy of 79% in predicting cirrhosis.
• No significant differences in marker levels were found between HCC and cirrhotic participants.

Conclusions:

• Specific immunologic markers play a significant role in the development of HBV-related cirrhosis.
• These markers show potential for predicting cirrhosis development in chronically HBV-infected individuals.
• Further validation is required, but findings emphasize the importance of immune processes in HBV pathogenesis.